IHS Chemical Week

Regions :: Western Europe :: U.K.

Lonza to Expand U.K. Facility

11:54 PM MDT | March 28, 2011 | Deepti Ramesh

Lonza says it will invest £16 million ($26 million) to expand its biopharmaceutical manufacturing facility at Slough, U.K., in order to respond to a broader range of customer projects and strengthen its global network of biologics development and manufacturing. The expansion project is expected to be completed by the end of 2012. The Slough site develops and manufactures antibodies and therapeutic proteins used in the clinical stages of drug development and ongoing commercial supply of marketed biopharmaceutical products. With the new investment, Lonza will...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa